baber/WOPTO huggingface dataset:
Patent NZ-544463-A (NZ)
Title: Nitrooxy derivatives of losartan, valsartan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-II receptor blockers for the treatment of cardiovascular diseases
Inventor: ALMIRANTE NICOLETTA
IPC: C07D235/20
Filed: 2004-07-20
Abstract: Disclosed are compounds of the formula R-(Y-ONO2)s, where s is 1 or 2, R is an angiotensin II receptor blocker residue of formula (II) or (III), and the remaining substituents are as defined in the specification. The compounds are useful in the treatment of cardiovascular diseases.
Patent NZ-544583-A (NZ)
Title: Bicyclic peptide imaging agents for in vivo diagnosis or imaging of a disease or condition associated with angiogenesis
Inventor: CUTHBERTSON ALAN
IPC: A61K47/48
Filed: 2004-07-21
Abstract: Disclosed is a bicyclic peptide of formula (I): wherein W1 is absent or represents a spacer moiety, Z1 is an antineoplastic agent, a chelating agent or a reporter moiety (such as a radionuclide, 18F), the other substituents are disclosed herein. The use of a compound of formula (I) as defined above in the manufacture of a composition for in vivo diagnosis or imaging of a disease or condition associated with angiogenesis, wherein when the composition is administered an image can be generated, of part or all of said body and wherein Z1 of the compound of formula (I) is a reporter moiety is also disclosed. Additionally, a radiopharmaceutical formulation comprising the above compound and one or more pharmaceutically acceptable excipients, wherein Z1 of the compound of formula (I) is a reporter moiety is also disclosed, as is a method and a kit for preparing the above compounds.
Patent NZ-547883-A (NZ)
Title: Cultured dairy products obtained without a whey separation step
Inventor: SWELEY JESS C
Filed: 2006-06-13
Abstract: Disclosed is a cultured cream cheese product which is prepared without a whey separation step and has reduced levels of cultured dairy materials. The process utilizes a first mixture of dairy ingredients which is homogenized and pasteurized, then cooled to about 68 to about 104 deg F. A lactic acid-producing bacterial culture is then added to the cooled first mixture and the mixture is cultured at a temperature and for a time sufficient to obtain a pH-stable mixture, wherein the stable pH is in the range of about 3.5 to about 5.5. A second mixture of dairy ingredients having dairy protein, salts, and gums is then added to the pH-stable cultured first mixture and the resulting third mixture is heated and homogenized at a temperature and for a time sufficient to obtain a cultured dairy product containing cultured and non-cultured dairy ingredients. The first amount of dairy protein is about 10 to about 40 percent and the second amount of dairy protein is about 60 to about 90 percent, based on the total amount of dairy protein, the cultured dairy product has a whey protein to casein ratio of greater than about 60:40, and the process does not include a whey-separation step.
Patent NZ-549433-A (NZ)
Title: Nappy with inner and outer panels forming a pocket for an insert
Inventor: POWELL JOLENE ANNE
Filed: 2006-08-25
Abstract: A nappy comprises an outer panel, an inner panel, and an insert arranged between the outer panel and the inner panel. The outer panel and the inner panel are made of a flexible material having a front edge and a rear edge and two side edges. The outer panel and the inner panel are attached about the front and side edges, and along the rear edges except for a portion of the rear edges to define an opening for allowing insertion of the insert. The areas about the rear edges and the front edges are adapted with a nappy fastening means, for fastening the nappy about the waist of a user. The side edges are scalloped between the front and rear edges to form a leg line, and the nappy includes an adjustable leg line means including elongate pockets formed in the inner panel adjacent the side edges to retain an elongate elastic member. The elastic member is provided with a plurality of fasteners in a spaced apart arrangement along the length of the elastic member to allow for the elastic member to be tightened or loosened to adjust the length of the side edges.
Patent NZ-549787-A (NZ)
Title: Antibodies binding to EphB4 for inhibiting angiogenesis and tumor growth
Inventor: KRASNOPEROV VALERY
IPC: C07K16/30
Filed: 2005-03-11
Abstract: Disclosed is an isolated monoclonal antibody or antigen binding portion thereof that binds to an epitope situated within specified amino acids of EphB4, inhibits binding of EphB4 to EphrinB2 and promotes apoptosis in a tumor cell. The antibody can be used in the treatment of cancer.
Patent NZ-550669-A (NZ)
Title: Shaker screen clamping and sealing assembly for recirculating drilling mud
Inventor: CARR BRIAN
IPC: B07B1/46
Filed: 2005-04-29
Abstract: An assembly for sealing a shaker screen 12 assembly in a shaker separator 10, wherein the shaker screen 12 assembly includes a screen frame defining an area and a screen cloth affixed to the screen frame across the area, and wherein the shaker separator 10 includes a plurality of shaker screen 12 supports affixed between opposing side walls and corresponding to the screen frame and upon which the screen frame is positioned, the assembly comprising a substantially inflexible gasket affixed to each of the plurality of shaker screen 12 supports and positioned between each shaker screen 12 support and the corresponding screen frame, a flexible gasket mounted to each of the plurality of shaker screen 12 supports adjacent to the inflexible gasket and positioned between each shaker screen 12 support and the corresponding screen frame, a wedge block retainer bracket affixed to each side wall and spaced above the corresponding screen frame at an angle thereto, a wedge block 14 selectively locatable between each wedge block retainer bracket and the corresponding screen frame to provide a force to the corresponding screen frame sufficient to seat the screen frame against the inflexible gasket and to deform the flexible gasket to provide a fluid tight seal between the shaker screen 12 supports and the screen frame.
Patent NZ-551500-A (NZ)
Title: Yoghurt product and process using divalent cation depleted milk
Inventor: BHASKAR GANUGAPATI VIJAYA
IPC: A23C9/123
Filed: 2006-11-23
Abstract: Disclosed is a method for preparing a set or stirred yoghurt comprising: a) preparing a divalent-cation-depleted milk composition comprising either depleting a starting milk composition of divalent cations, or including within a starting milk composition a divalent-cation-depleted milk ingredient selected from milk, fat standardised milk, skim milk, or milk concentrate, and b) acidifying the divalent-cation-depleted milk composition with chemical acidification or lactic-acid- producing bacteria, to prepare a yoghurt, wherein the divalent cation depletion is by contacting the milk composition or ingredient with a cation exchanger to replace divalent cations in the composition or ingredient with sodium or potassium.
Patent NZ-551817-A (NZ)
Title: Ethylene-vinyl alcohol copolymer and molded article thereof
Inventor: SHIBUTANI MITSUO
IPC: B32B27/28
Filed: 2004-12-17
Abstract: Disclosed is an ethylene-vinyl alcohol copolymer comprising the structural unit of formula (1), wherein X represents a binding chain excluding an ether bond, each of R1 to R4 represents independently a substituent and n represents 0 or 1, characterised in that: a) the copolymer has an ethylene content of 20% to 60% by mol; b) the copolymer comprises an amount of formula (1) of 1% to 10% by mol; c) the copolymer has been subjected to a degree of hydrolysis of at least 90% by mol; d) the copolymer has a melt flow rate (MFR) of 0.1 to 100g/10 minutes at 210C and a load of 2160 g; and e) the copolymer is able to impart stretching properties and the binding chain and substituent are compatible with that result.
Patent NZ-563587-A (NZ)
Title: Pillow selection and sleeper appraisal
Inventor: MACFARLANE ANDREW ROBERT
IPC: A41H1/00
Filed: 2006-05-23
Abstract: A neck measurement device (20) and a method of selecting a pillow which takes into account the physique of the user are disclosed. The device comprises of a body having a corner and two straight edges perpendicular to each other. One surface of the body has a scale (21, 22) extending along an edge with regularly spaced marked indicia. The indicia are mirror reversed so a user can read the indicia in the mirror whilst using the device. A method of using such a device includes using weight data to determine an index which has corresponding pillows.
Patent NZ-565470-A (NZ)
Title: Novel heterocyclic NF-kB inhibitors
Inventor: LEBAN JOHANN
IPC: A61K31/4535
Filed: 2006-03-15
Abstract: Disclosed are amide compounds of formula (Ih) that have a substituted five-member heteocyclic ring connected to an optionally substituted fused aromatic bicyclic ring system. The 5-membered ring is either: thiazole, imidazole or oxazole and the fused ring is benzimidazole, benzoxazole or benzothiazole. The variables are as disclosed in the specification. Also disclosed is the use of the compound or a composition containing the compound to treat diseases characterized by hyperproliferation of cells in particular from ischemia, reperfusion injury of organs and/or of parts of the body selected from the group comprising heart, brain, peripheral limb, kidney, liver, spleen and lung, wherein the endothelial dysfunction is associated with diseases selected from a group comprising infarctions such as myocardial infarction and critical limb ischemia, and/or wherein the endothelial dysfunction is associated with diseases selected from the group comprising ischemic diseases, myocardial infarction and ischemic diseases of organs, neurological diseases or disorders selected from the group comprising Alzheimer's disease, Parkinson's disease, Creutzfeld-Jacob Disease, Lewy Body Dementia, amyotrophic lateral sclerosis, stroke, epilepsy, multiple sclerosis, myasthenia gravis, Huntington's Disease,· Down's Syndrome, nerve deafness, and Meniere's disease, psoriasis, atopic dermatitis, alopecia areata, alopecia totaIis, alopecia subtotalis, alopecia universalis, alopecia diffusa, lupus erythematodes of the skin, lichen planus, dermatomyostis of the skin, atopic eczema, morphea, sklerodermia, psoriasis vulgaris, psoriasis capitis, psoriasis guttata, psoriasis inversa, alopecia areata ophiasis-type, androgenetic alopecia, allergic contact eczema, irritative contact eczema, contact eczema, pemphigus vulgaris, pemphigus foliaceus, pemphigus vegetans, scarring mucosal pemphigoid, bullous pemphgoid, mucous pemphigoid, dermatitis, dermatitis herpetiformis duhring, urticaria, necrobiosis lipoidica, erythema nodosum, lichen vidal, prurigo simplex, prurigo nodularis, prurigo acuta, linear IgA dermatosis, polymorphic light dermatoses, erythema solaris, lichen sclerosus et atrophicans, exanthema of the skin, drug exanthema, purpura chronica progressiva, dihidrotic ekzema, Ekzema, fixed drug exanthema, photoallergic skin reaction, lichen simpfex eriorale, dermatitis and "Graft versus Host-Disease", acne, rosacea, scarring, keloids, vitiligo, actinic keratoses, hyperkeratoses like epidermolytic hyperkeratosis, Hyperkeratosis Lenticularis Perstans, Keratosis pilaris and Ichthyoses.
Patent NZ-586275-A (NZ)
Title: A method of monitoring bulk (total) microbiological activity in process streams
Inventor: RICE LAURA E
IPC: G01N33/18
Filed: 2008-11-19
Abstract: A method for monitoring and controlling the bulk (total) microbiological water activity in a process stream. The method comprises the steps: (a) Connecting an apparatus to a process stream, wherein the apparatus comprises a flow cell containing a plurality of openings, wherein at least one opening is a flow cell inlet for fluid drawn from the process stream and at least one opening is a flow cell outlet for fluid exiting the flow cell, a Dissolved Oxygen (DO) probe attached to one of the openings and optionally any of the following: an ORP probe attached to one of the openings, a cleaning device, a conduit attached to the flow cell inlet or outlet and a valve associated with the flow cell; (b) Opening the valve of the apparatus to allow fluid to be drawn into the flow cell; (c) Drawing fluid from the process stream into the flow cell; (d) Measuring the DO concentration of the process stream with the DO probe, and wherein prior to each measurement the surface of the DO probe is cleaned; (e) Closing the valve of the apparatus to prevent fluid from being drawn into the flow cell; (f) Measuring the DO concentration of the fluid inside the apparatus with the DO probe, an wherein prior to each measurement the surface of the DO probe is cleaned; (g) Calculating a delta DO reading between step (d) and step (f); (h) Correlating the delta DO value in step (g) with bulk (total) microbiological activity in the process stream; and (i) Controlling the amount of microbiological activity by adding an effective amount of a treatment containing one or more oxidising and/or non-oxidising biocides to the process stream and optionally a mixture containing a n-hydrogen compound, an oxidizing biocide and optionally a buffer to the process stream. The process stream can be a papermaking, hydroentangling non-woven or fiberglass mat process steam.
Patent NZ-588976-A (NZ)
Title: Fluidized bed reactor
Inventor: ZIMMER SEBASTIAN
IPC: B01J8/00
Filed: 2006-06-02
Abstract: A fluidised bed reactor 1 with one or several openings 6 evenly distributed across the circumference, which allows refluxing solids, other solids and agglomerates to be discharged separately from the gas/gas stream. (62) Divided Out of 564804
Patent NZ-594731-A (NZ)
Title: Service policy implementation using device agents on a wireless device
Inventor: RALEIGH GREGORY G
IPC: H04W4/24
Filed: 2010-01-15
Abstract: 594731 Disclosed is a wireless end-point device (100) with one or more modems (940, 942, 944, 946, 948, 949) for enabling the wireless end-point device (100) to communicate with a network element (960) over a wireless access network. A service-processor execution environment is included which has one or more storage elements (910) configured to store a service policy having a multi-level configuration such that the multi-level configuration reduces communication overhead associated with managing or implementing the service policy. The service policy includes a high-level service policy objective and one or more low-level policy agent instructions, and is associated with a service activity available to the wireless end-point device (100). A service processor (115) has a plurality of service processor agents which includes a policy control agent and one or more low-level policy agents. The service processor (115) establishes a secure service control link over the wireless access network between the wireless end-point device (100) and the network element (960), and obtains at least a portion of the service policy from the network element (960) over the secure service control link. The policy control agent obtains a service activity condition associated with the service activity such that the service activity condition includes a service activity current state or a service activity history. Based on the service activity condition and the high-level service policy objective, a set of one or more particular low-level policy agent instructions are determined and provided from the one or more low-level policy agent instructions, to at least one of the one or more low-level policy agents. The at least one of the one or more low-level policy agents is configured to implement the set of one or more particular low-level policy agent instructions.
Patent NZ-595199-A (NZ)
Title: Synergistic herbicidal composition containing florasulam for weed control in turf
Inventor: LOUGHNER DANIEL
IPC: A01N43/40
Filed: 2010-04-14
Abstract: Provided is a synergistic herbicidal mixture comprising an herbicidally effective amount of (a) florasulam and (b) at least one pre-emergent annual grass herbicide selected from the group consisting of dithiopyr and pendimethalin.
Patent NZ-612224-A (NZ)
Title: Quinazoline carboxamide azetidines
Inventor: HUCK BAYARD R
IPC: C07D403/12
Filed: 2011-11-11
Abstract: Provided are quinazoline carboxamide azetidine compounds, of general formula (I), where the variables are as defined in the specification. Particularly preferred compounds are of the general formula (II’). Examples of the compounds include 4-[(S)-2-Azetidin-1-yl-1-(3-fluorophenyl)-ethylamino]-quinazoline-8-carboxylic acid amide and 4-[(S)-2-(3-Fluoro-azetidin-1-yl)-1-(4-chloro-3-trifluoromethyl-phenyl)-ethylamino]quinazoline-8-carboxylic acid amide. The compounds are inhibitors of p70S6 kinase (p70S6K). The compounds are useful in the treatment of hyperproliferative diseases such as cancer, inflammation, pancreatitis or kidney disease, pain, benign hyperplasia of the skin, restenosis, prostate, diseases related to vasculogenesis or angiogenesis, tumor angiogenesis, skin diseases selected from psoriasis, eczema, and sclerodema, diabetes, diabetic retinopathy, retinopathy of prematurity, age-related macular degeneration, hemangioma, glioma, melanoma and Kaposi’s sarcoma.
Patent NZ-615544-A (NZ)
Title: A prognostic and therapeutic signature for malignant melanoma
Inventor: MEYER STEFANIE
IPC: G01N33/574
Filed: 2012-03-30
Abstract: Discloses a method of predicting the course of disease in a patient having a malignant melanoma, the method comprising determining in melanoma cells comprised in a sample obtained from said malignant melanoma the presence or amount of at least five biomarkers selected from the group comprising or consisting of MTAP, PTEN, Bax, Bcl-X, beta-Catenin, CD20, Cox-2, CD49d and MLH1, wherein the absence or decreased amount of MTAP and beta-Catenin and/or the presence or increased amount of PTEN, Bax, Bcl-X, CD20, Cox-2, CD49d and MLH1 is associated with a disadvantageous course of disease. Also discloses a method of preparing a tailored pharmaceutical composition for a patient having a malignant melanoma using the same biomarkers.
Patent NZ-620032-A (NZ)
Title: Processing materials with ion beams
Inventor: MEDOFF MARSHALL
IPC: C10G19/00
Filed: 2009-06-17
Abstract: The disclosure relates to a method of making a fuel, which comprises the steps of: irradiating a cellulosic or lignocellulosic material with an ion beam comprising a first distribution of ion energies having a full width at half maximum of W and a second distribution of energies with a full width at half maximum W2 of more than W; and converting the irradiated material to produce a fuel, wherein the irradiated material is converted utilizing a bacteria or yeast, and wherein the fuel is ethanol, butanol or hydrogen.
Patent NZ-622539-A (NZ)
Title: Diphenoxyphenyl derivative
Inventor: NAGANAWA ATSUSHI
IPC: C07D405/12
Filed: 2012-09-27
Abstract: The disclosure relates to a family of compounds represented by general formula (I-1) (where all of the symbols are as defined in the specification) and its use as a S1P2 antagonist. The disclosure also relates to the use of this compounds use as a therapeutic agent for S1P-mediated disease, such as vasoconstriction-related disease, fibrosis, respiratory disease, and the like. Example compounds include: 4-(2-ethylbutyl)-N-{ 3-[4-(ethylcarbamoyl)phenoxy]-5-(4-fluorophenoxy)phenyl} -4-hydroxy-1-piperidine carboxamide, 4-[3-(4-fluorophenoxy)-5-({ [4-(4-fluorophenyl)-4-hydroxyl-piperidinyl]carbonyl} amino)phenoxy]benzoic acid, 4-(2-ethylbutyl)-N-[3-(4-fluorophenoxy)-5-{ 4-[(4-hydroxyl-piperidinyl)carbonyl]phenoxy} phenyl]-4-hydroxy-1-piperidinyl)carbonyl]phenoxy} phenyl]-4-hydroxy-1-piperidinecarboxamide, 2-{ 4-[3-(4-fluorophenoxy)-5-{ [(4-’hydroxy-4-isobutyl-1-piperidinyl)carbonyl]amino} phenoxy]phenyl} -2-methylpropanoic acid, 4-[3-({ [4-(2-ethylbutyl)-4-hydroxy-1-piperidinyl]carbonyl} amino)-5-(4-fluorophenoxy)phenoxy]benzoic acid, 2-{ 4-[3-({ [4-(2-ethylbutyl)-4-hydroxy-1-piperidinyl]carbonyl} amino)-5-(4-fluorophenoxy)phenoxy]phenyl} -2-methylpropanoic acid, 2-(4-{ [3-(4-fluorophenoxy)-5-{ [(4-hydroxy-4-isobutyl-lpiperidinyl)carbonyl]amino} benzoyl]oxy} phenyl)-2-methylpropanoic acid.
Patent NZ-702677-A (NZ)
Title: Microstructure-based wound closure devices
Inventor: ROLANDI MARCO
IPC: B81C1/00
Filed: 2013-06-17
Abstract: The present invention relates generally to wound closure devices comprising one or more microstructures. The devices are designed such that the microstructures are able to grip the skin or tissue surrounding a wound, optionally closing the wound, or securing the tissue or skin in place. Also provided are wound closure systems that comprise one or more microstructure wound closure devices along with other components, such as protective covers and wound healing therapeutics. A variety of packaging specifications are disclosed, as is a dispenser apparatus configured to enable simple one-handed application of the wound closure devices. Methods described herein provide for the closure of various wounds with the wound closure devices and systems.
Patent NZ-711226-A (NZ)
Title: A mattress for ready changing of bed linen
Inventor: MARTIN DAVID JOHN
IPC: A47C31/08
Filed: 2014-02-07
Abstract: A mattress for bedding which addresses problems associated with handling, for example when fitting sheets thereto. The mattress includes a number of elongate members, webs or straps that span an underside of the mattress and terminate with graspable handle portions. The straps are directly attached to the underside of the mattress by a hook and loop fastening system. A mattress prop may be used in conjunction with the straps for spacing the mattress from a support surface such as a bed base. In a first version the prop has a mattress attachment member and a base abutment member movable relative to the mattress attachment member from a collapsed configuration to an erected configuration. A spacer member is disposed between the mattress attachment member and the base abutment member for selectively retaining the base abutment member in the erected configuration relative to the mattress attachment member.
Patent NZ-715015-A (NZ)
Title: Wind turbine
Inventor: BERENTS GERD
IPC: H01C7/12
Filed: 2014-06-16
Abstract: What is provided is: a wind turbine comprising a rotor having at least two rotor blades, an electrical generator, which is coupled directly or indirectly to the rotor and generates an electric power, and at least one power electronics unit, which is provided for converting an input voltage with an input frequency into an output voltage with an output frequency. The power electronics unit has at least one varistor unit. The varistor unit has at least one varistor disk having a voltage-dependent resistance and at least one metal disk which is provided in contact with the at least one varistor disk and is provided as cooling element for cooling the varistor disk.
Patent NZ-721199-A (NZ)
Title: Bow coupling device
Inventor: VAN DER HORST ARJEN
IPC: E02F9/06
Filed: 2014-12-18
Abstract: The invention relates to a method for coupling a manoeuvrable vessel (1) to a floating structure (2), the method comprising; - providing a pickup system (3) coupled to the floating structure, the pickup system comprising a float (4), - providing a vessel coupling system (5) comprising manoeuvrable coupling means (6) on the manoeuvrable vessel, - aiming the manoeuvrable coupling means towards the pickup system, - guiding the manoeuvrable coupling means into float coupling means (7) of the pickup system, such that the manoeuvrable coupling means is accommodated in to the float coupling means, - locking the manoeuvrable coupling means into the float coupling means, such that a coupling connection between the manoeuvrable vessel and the floating structure is established, - connecting the floating structure to the coupling vessel.